Erica Daina - Concepedia

Author

Erica Daina

Mario Negri Institute for Pharmacological Research ORCID

Also Known As

Arrigo Schieppati, Comai Giorgia, Daina Erica, Daina, E., Daina, Erica, E Daina, E. Daina, E., Daina, ERICA DAINA, Erica Daina

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Mario Negri Institute for Pharmacological Research Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Papa Giovanni XXIII University of Milan Columbia University Irving Medical Center

About

Erica Daina is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, nephrology, and glomerulonephritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.8K
2	Business	1	1	154
3	Health Sciences	1	1	154
4	Public Health	1	1	79
5	Economics	1	1	154

Erica Daina

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype Marina Noris, Jessica Caprioli, Elena Bresin, Clinical Journal of the American Society of Nephrology	2010	1K
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. Flavio Gaspari, Norberto Perico, Piero Ruggenenti, Journal of the American Society of Nephrology PharmacokineticsGlomerulonephritisRenal FunctionBioanalysisRenal Clearance	1995	370
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease Jessica Caprioli, Federica Castelletti, Sara Bucchioni, Human Molecular Genetics HlaHistocompatibilityHf1 MutationsComplete Hf1Genetic Epidemiology	2003	306
Takayasu's arteritis: A study of 104 Italian patients M. Vanoli, Erica Daina, Carlo Salvarani, Arthritis Care & Research	2005	304
The Molecular Basis of Familial Hemolytic Uremic Syndrome Jessica Caprioli, Paola Bettinaglio, Peter F. Zipfel, Journal of the American Society of Nephrology	2001	287
Interleukin-6 and RANTES in Takayasu Arteritis Marina Noris, Erica Daina, Sara Gamba, Circulation	1999	237
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Giuseppe Remuzzi, Miriam Galbusera, Marina Noris, Blood	2002	192
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome Paraskevas Iatropoulos, Marina Noris, Caterina Mele, Molecular Immunology Glomerular DiseaseRenal PathologyGenetic EpidemiologyImmunologyPathology	2016	177

Page 1